Drug
YG 01 Dose Level 1
YG 01 Dose Level 1: highest development phase Phase 1, developed by YGION Biomedical GmbH. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- YGION Biomedical GmbH
Trials
| Drug | Phase | Indication |
|---|---|---|
| YG-01 Dose Level 1 NCT07930338 | Phase 1 | Glioblastoma |
Latest
No recent events.
Follow YG 01 Dose Level 1 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.